ISIN | LU2851596101 |
---|---|
Valor Number | 136501270 |
Bloomberg Global ID | |
Fund Name | Swisscanto (LU) Equity Fund Sustainable Healthy Longevity ST |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | Swisscanto Fondsleitung AG |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The total commitments of the fund may not amount to more than 210% as a result of the use of derivatives (max. 100%) and temporary borrowing (max. 10%). |
Peculiarities |
Current Price * | 88,794.91 EUR | 11.04.2025 |
---|---|---|
Previous Price * | 88,845.89 EUR | 10.04.2025 |
52 Week High * | 104,927.47 EUR | 30.01.2025 |
52 Week Low * | 88,696.30 EUR | 08.04.2025 |
NAV * | 88,794.91 EUR | 11.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 82,264,459 | |
Unit/Share Assets *** | 8,887 | |
Trading Information SIX |
YTD Performance | -10.44% |
31.12.2024 - 11.04.2025
31.12.2024 11.04.2025 |
---|---|---|
YTD Performance (in CHF) | -11.75% |
31.12.2024 - 11.04.2025
31.12.2024 11.04.2025 |
1 month | -8.00% |
11.03.2025 - 11.04.2025
11.03.2025 11.04.2025 |
3 months | -12.10% |
13.01.2025 - 11.04.2025
13.01.2025 11.04.2025 |
6 months | -12.27% |
11.10.2024 - 11.04.2025
11.10.2024 11.04.2025 |
1 year | -11.21% |
27.08.2024 - 11.04.2025
27.08.2024 11.04.2025 |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | 92.46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 4.33% | |
---|---|---|
Fresenius SE & Co KGaA | 3.75% | |
Haleon PLC | 3.62% | |
Abbott Laboratories | 3.53% | |
BioMerieux SA | 3.09% | |
UnitedHealth Group Inc | 2.89% | |
Sandoz Group AG Registered Shares | 2.86% | |
Halma PLC | 2.84% | |
Cardinal Health Inc | 2.76% | |
Unum Group | 2.59% | |
Last data update | 30.04.2025 |
TER *** | 0.01% |
---|---|
TER date *** | 30.09.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | 0.01% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |